EW

Edwards Lifesciences Corp · Manufacturing · Market cap $51.0B

Insiders sold $4.5M net in the last 90 days ·6 sellers, 0 buyers· 3 of 10 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 8, 2026

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$27.7M

reported sales (SEC code S)

Unique Insiders

9

in the rolling window

Latest filing

Oct 8, 2026

Lippis Daniel J.

Edwards Lifesciences Corp (EW) has 75 SEC Form 4 filings (157 transaction rows) in the rolling window, disclosed by 9 distinct insiders. Most recent filing: Oct 8, 2026.

Inside the rolling window, 9 insiders at Edwards Lifesciences Corp reported no open-market purchases and 43 open-market sales totaling $27.7M. The most active filer is CVP, TAVR Lippis Daniel J. with 13 filings. Insiders have net sold $11.4M over the trailing 6 months. The most recent open-market filing is a sale of 619 shares by CVP, TAVR Lippis Daniel J., dated Oct 8, 2026, worth $53K.

  • Industry:Medical - Devices
  • CEO:Bernard J. Zovighian
  • Employees:16,000
  • HQ:Irvine, CA, US
  • IPO:2000-03-27
Source
Sale$53KOct 8SEC ↗
Sale$54KSep 11SEC ↗
Dahl Andrew M.First in 3 months
Sale$50KAug 31SEC ↗
Bruls AnnetteFirst filing
Sale$238KAug 28SEC ↗
Sale$113KAug 26SEC ↗
Chopra DaveenFirst in 3 months
Sale$2.9MAug 26SEC ↗
Sale$57KAug 11SEC ↗
Sale$13KJul 30SEC ↗
Sale$819KJul 28SEC ↗
Sale$245KJul 27SEC ↗
Sale$57KJul 10SEC ↗
Sale$57KJul 1SEC ↗
Sale$46KJun 17SEC ↗
Dahl Andrew M.First filing
Sale$49KMay 29SEC ↗
Sale$2.0MMay 27SEC ↗
Chopra DaveenFirst in 5 months
Sale$127KMay 22SEC ↗
Sale$50KMay 18SEC ↗
Sale$1.5MMay 18SEC ↗
Sale$2.8MMay 12SEC ↗
Markowitz WayneFirst in 5 months
Sale$47KMay 12SEC ↗
Sale$85KMay 4SEC ↗
Sale$86KMay 4SEC ↗
Sale$1.0MApr 9SEC ↗
Sale$83KApr 6SEC ↗
Sale$1.8MApr 2SEC ↗
Showing 1–25 of 43
1 / 2

Congress trading EW 66 all-time

  • DRep. Ro KhannaPurchase$1,001 - $15,0002026-05-01
  • DRep. Ro KhannaPurchase$1,001 - $15,0002026-05-01
  • DRep. Ro KhannaSale$1,001 - $15,0002026-01-13
  • DRep. Josh S. GottheimerSale$1,001 - $15,0002025-11-19
  • DRep. Ro KhannaSale$1,001 - $15,0002025-10-07
  • RRep. Bruce WestermanSale$1,001 - $15,0002025-04-21

STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.

Frequently asked questions

How many SEC Form 4 insider filings does EW have?

Edwards Lifesciences Corp (EW) has 75 SEC Form 4 filings (157 transaction rows) in the rolling 365-day window, disclosed by 9 distinct insiders. Most recent filing: Oct 8, 2026.

When was the most recent SEC Form 4 filing for EW?

The most recent Form 4 filing for EW on Tracefour is dated Oct 8, 2026.

Who is the most active insider at EW?

The most active SEC Form 4 filer at EW in the rolling window is CVP, TAVR Lippis Daniel J., with 13 filings.

What is the net insider flow at EW over the last 6 months?

Over the trailing 180 days, insiders at EW have net sold $11.4M based on SEC Form 4 disclosures.

What is the total insider buy and sell value at EW in the current window?

Inside the rolling window, insiders at EW bought $0 and sold $27.7M based on SEC Form 4 filings.

Can I get alerts for EW insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Edwards Lifesciences Corp (EW). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Edwards Lifesciences Corp is in the Manufacturing sector.